Can a cannabis drug soothe Alzheimer's agitation? new trial aims to find out.
Symptom relief
Not yet recruiting
This study tests whether dronabinol, a cannabis-based oral solution, can reduce agitation in people with Alzheimer's disease. About 140 adults aged 50-90 will receive either the drug or a placebo for 12 weeks, followed by a 6-month period where everyone gets dronabinol. The goal …
Phase: PHASE2, PHASE3 • Sponsor: Benuvia Therapeutics Inc. • Aim: Symptom relief
Last updated May 04, 2026 05:02 UTC